Director/PDMR Shareholding

RNS Number : 8006Q
BB Healthcare Trust PLC
29 October 2021
 

BB Healthcare Trust plc

Directors Dealings

BB Healthcare Trust plc announces that the undermentioned directors of the Company on 28 October 2021 sold and immediately repurchased Ordinary Shares through a Bed and ISA arrangement, in order to effect the transfer of the Ordinary Shares to their respective ISA accounts.

The transactions are summarised below:

 Director

Shares sold

Shares acquired

Total holding following notification

% of current issued Ordinary Share capital

Randeep Grewal

9,250

9,250

97,247

0.01750%

Kate Bolsover

3,116

3,116

3,116

0.00056%

 

The notification can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Randeep Grewal

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

BB Healthcare Trust plc

b)

 

LEI

 

 

 

213800HQ3J3H9YF2UI82

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

Identification code

ISIN

GB00BZCNLL95

 

 

 

b)

 

Nature of the transaction

 

 

Sale of 9,250 Ordinary Shares and repurchase of 9,250 Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

Transaction 1 (sale)

 

197.4334p per share

9,250

 

Transaction 2 (purchase)

 

197.41p per share

9,250

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

Sale: 9,250

Purchase: 9,250

 

 

- Price

Total price sale: £18,262.59

Total price purchase: £18,260.43

 

 

 

e)

 

Date of the transaction

 

 

28 October 2021 (Transaction 1)

28 October 2021 (Transaction 2)

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kate Bolsover

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

BB Healthcare Trust plc

b)

 

LEI

 

 

 

213800HQ3J3H9YF2UI82

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 

Identification code

ISIN

GB00BZCNLL95

 

 

 

b)

 

Nature of the transaction

 

 

Sale of 3,116 Ordinary Shares and repurchase of 3,116 Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

Transaction 1 (sale)

 

197p per share

3,116

 

Transaction 2 (purchase)

 

197p per share

3,116

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

Sale: 3,116

Purchase: 3,116

 

 

- Price

Total price sale: £6,138.52

Total price purchase: £6,138.52

 

 

 

e)

 

Date of the transaction

 

 

28 October 2021 (Transaction 1)

28 October 2021 (Transaction 2)

f)

 

Place of the transaction

 

 

London Stock Exchange

 

Enquiries:

 

Ciara McKillop

020 7653 9690

PraxisIFM Fund Services (UK) Limited

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKLFLFBLZFBL
UK 100

Latest directors dealings